Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Madrigal Pharmaceuticals (MDGL) Other Working Capital Changes (2019 - 2025)

Historic Other Working Capital Changes for Madrigal Pharmaceuticals (MDGL) over the last 13 years, with Q3 2025 value amounting to -$9.3 million.

  • Madrigal Pharmaceuticals' Other Working Capital Changes fell 25725.67% to -$9.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 6044.64%. This contributed to the annual value of $10.6 million for FY2024, which is 181639.64% up from last year.
  • Madrigal Pharmaceuticals' Other Working Capital Changes amounted to -$9.3 million in Q3 2025, which was down 25725.67% from $35.4 million recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Other Working Capital Changes registered a high of $35.4 million during Q2 2025, and its lowest value of -$9.3 million during Q3 2025.
  • In the last 5 years, Madrigal Pharmaceuticals' Other Working Capital Changes had a median value of $928000.0 in 2024 and averaged $2.5 million.
  • Examining YoY changes over the last 5 years, Madrigal Pharmaceuticals' Other Working Capital Changes showed a top increase of 1009661.02% in 2024 and a maximum decrease of 2220937.5% in 2024.
  • Quarter analysis of 5 years shows Madrigal Pharmaceuticals' Other Working Capital Changes stood at -$2.5 million in 2021, then soared by 46.44% to -$1.3 million in 2022, then soared by 102.42% to $32000.0 in 2023, then plummeted by 22209.38% to -$7.1 million in 2024, then tumbled by 31.1% to -$9.3 million in 2025.
  • Its Other Working Capital Changes was -$9.3 million in Q3 2025, compared to $35.4 million in Q2 2025 and $9.5 million in Q1 2025.